Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
David W. Gryska currently holds 17,351 shares of PDL BIOPHARMA, INC. (PDLI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David W. Gryska has been a net seller of PDLI stock. They have purchased $20.9K and sold $23.7M worth of shares.
David W. Gryska's most recent insider trade was on Aug 23, 2024, when they purchased 3,500 shares at $5.98 per share.
David W. Gryska serves as Executive at PDL BIOPHARMA, INC. (PDLI). They have executed 137 insider transactions totaling $23.7M over their tenure at the company.
David W. Gryska holds the position of Executive at PDL BIOPHARMA, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
David W. Gryska has shown a selling trading pattern, with $20.9K in total purchases and $23.7M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by David W. Gryska was on Dec 14, 2023, when they sold $11.2M worth of SGEN shares. This transaction involved 49,003 shares at $229.00 per share.
David W. Gryska currently owns 17,351 shares of PDL BIOPHARMA, INC. (PDLI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of David W. Gryska's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. David W. Gryska has 137 Form 4 filings on record as an insider at PDL BIOPHARMA, INC..
Set alerts for David W. Gryska and 40,000+ other insiders.